Journal
RESPIRATORY MEDICINE
Volume 210, Issue -, Pages -Publisher
W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2023.107125
Keywords
Allergen immunotherapy; Mechanisms; Clinical effectiveness; Prevention; Disease remission; Asthma; Disease modification
Ask authors/readers for more resources
Allergen specific immunotherapy (AIT) is the only causal therapeutic option for allergic airway diseases. Recent real life data on long-term effectiveness of AIT further underscored its unique therapeutic potential. More widespread use of this treatment should further move this promising therapeutic field.
Allergen specific immunotherapy (AIT) is the only causal therapeutic option for allergic airway diseases including asthma and allergic rhinitis. AIT has been shown to restore the allergen immune tolerance, can modify both the early and late-onset allergen-specific airway hyperreactivity, helps to achieve disease control/remission and prevents new sensitisations. Recent real life data on long-term effectiveness of house dust mite (HDM) AIT in a large group of patients with HDM-driven asthma further underscored its unique therapeutic potential as well as confirmed previous data with pollen AIT. More widespread use of this causal treatment in select patient populations should further move this promising therapeutic field. In this mini-review, we discuss updates on new insights based on real world patient data.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available